Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (541-550 of 738) with videos related to

Pageof 74
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE TrialDavid M Charytan, Jie Yu, Meg J Jardine, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
Circulation|March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Matthew A Cavender, William B White, Petr Jarolim, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)Jennifer J Gassman, Tom Greene, Jackson T Wright, et al.
Atherosclerosis|November 3, 2015
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUSRishi Puri, Steven E Nissen, Venu Menon, et al.
Cardiorenal Medicine|January 20, 2012
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney DiseaseGeorges Saab, Adam Whaley-Connell, Andrew Bombeck, et al.
The Lancet. Diabetes & Endocrinology|November 11, 2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trialDick de Zeeuw, Ronny W Renfurm, George Bakris, et al.
Diabetes Care|September 3, 2010
Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP)Andrew S Bomback, Yelena Rekhtman, Adam T Whaley-Connell, et al.
Journal of the American College of Cardiology|March 15, 2018
Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 DiabetesStephen J Greene, Muthiah Vaduganathan, Muhammad Shahzeb Khan, et al.
ESC Heart Failure|December 24, 2024
Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)Jan Biegus, JoAnn Lindenfeld, G Michael Felker, et al.
Pageof 74

Showing results (541-550 of 738) with videos related to

Sort By:
Pageof 74
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE TrialDavid M Charytan, Jie Yu, Meg J Jardine, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
Circulation|March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Matthew A Cavender, William B White, Petr Jarolim, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)Jennifer J Gassman, Tom Greene, Jackson T Wright, et al.
Atherosclerosis|November 3, 2015
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUSRishi Puri, Steven E Nissen, Venu Menon, et al.
Cardiorenal Medicine|January 20, 2012
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney DiseaseGeorges Saab, Adam Whaley-Connell, Andrew Bombeck, et al.
The Lancet. Diabetes & Endocrinology|November 11, 2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trialDick de Zeeuw, Ronny W Renfurm, George Bakris, et al.
Diabetes Care|September 3, 2010
Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP)Andrew S Bomback, Yelena Rekhtman, Adam T Whaley-Connell, et al.
Journal of the American College of Cardiology|March 15, 2018
Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 DiabetesStephen J Greene, Muthiah Vaduganathan, Muhammad Shahzeb Khan, et al.
ESC Heart Failure|December 24, 2024
Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)Jan Biegus, JoAnn Lindenfeld, G Michael Felker, et al.
Pageof 74